Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateDivestiture29 Jul 2026

REC Ltd

Intimation of sale and transfer of project specific SPVs/Subsidiaries.

REC Ltd has sold two project-specific subsidiaries, Bhadla Ramgarh Power Transmission Limited and Shongtong Power Transmission Limited, to Power Grid Corporation of India and Terralight Solar Energy Tinwari Private Limited respectively, for a total consideration of ₹12,85,79,427 and ₹20,40,66,599 respectively.

Read more →📎 1 attachment
BSECompany UpdateResults29 Jul 2026

Zensar Technologies Ltd

Investor Presentation

Zensar Technologies Ltd reported Q1FY27 revenue of $159.5M, a 1.1% sequential constant currency growth, with Banking and Financial Services registering a QoQ revenue growth of 8.3% and quarterly YoY growth of 14.7% in constant currency. The company reported a QoQ decrease of 220 bps in Profit after tax at 12.2% of revenue.

Read more →📎 1 attachment
BSECompany UpdateAuditor Change29 Jul 2026

Chemfab Alkalis Ltd

Submission of approval by the Board of Directors, the appointment of Statutory Auditors, M/s. MSKA & Associates LLP (FRN 001595S/S000168) at its meeting held on 29th July 2026, subject ....

Chemfab Alkalis Ltd has submitted the approval of the Board of Directors for the appointment of Statutory Auditors, M/s. MSKA & Associates LLP, for the first term of five consecutive years, subject to shareholder approval at the ensuing Annual General Meeting.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change29 Jul 2026

Novartis India Ltd

The Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e, Wednesday, July 29, 2026 took note of the Resignation of Mr. Christopher David Snook as ....

Novartis India Ltd's Board of Directors took note of the resignation of Mr. Christopher David Snook as Chairman and the completion of the sale of 17,450,680 equity shares from Novartis AG to WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners. The Board also reclassified Novartis AG from the 'promoter' category to 'public' category and appointed new directors.

Read more →📎 1 attachment
BSEResultResults29 Jul 2026

Zensar Technologies Ltd

Outcome of Board Meeting

Zensar Technologies Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with revenue from operations at ₹7,632 million and net profit after tax at ₹1,835 million.

Read more →📎 1 attachment
BSEBoard MeetingResults29 Jul 2026

OnEMI Technology Solutions Ltd

Outcome of Board meeting to approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.

OnEMI Technology Solutions Ltd has announced the outcome of its board meeting, approving the unaudited financial results for the quarter ended June 30, 2026. The results were reviewed and recommended by the Audit Committee, and the Statutory Auditors have given an unmodified opinion. The company has also appointed a Secretarial Auditor for five consecutive years.

Read more →📎 1 attachment
BSEBoard MeetingResults29 Jul 2026

Zensar Technologies Ltd

Financial Results for Quarter ended June 30, 2026

Zensar Technologies Ltd announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net profit after tax of ₹1,835 crore. The company's revenue from operations was ₹7,632 crore, and its total income was ₹8,366 crore. The financial results were approved by the Board of Directors and reviewed by the independent auditor SR 8 C & CO LLP.

Read more →📎 1 attachment
BSECompany UpdatePromoter Reclassif.29 Jul 2026

Novartis India Ltd

The Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e, Wednesday, July 29, 2026 took note of the Resignation of the Directors of the company.

Novartis India Ltd's board of directors has taken note of the resignation of certain directors and the completion of the sale of 17,450,680 equity shares by Novartis AG to WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners. The sale has resulted in Novartis AG ceasing to be in control of the company and being reclassified from a promoter to a public category. The board has also appointed new directors, including additional non-executive and independent directors.

Read more →📎 1 attachment
← PreviousPage 2552 of 3070Next →